Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Source Sato et al., 2011 · Hubrecht Institute, KNAW and University Medical Centre Utrecht · 10.1053/j.gastro.2011.07.050
Abstract
This protocol establishes long-term culture conditions for expanding human intestinal epithelial organoids from normal colon, colorectal adenomas, adenocarcinomas, and Barrett's esophageal metaplasia. The system allows robust growth of primary human gastrointestinal epithelial tissues for extended periods with minimal genetic changes, enabling studies of infected, inflammatory, and neoplastic gastrointestinal tissues.
Protocol overview
21 steps across 6 phases
- 1 Collect and prepare human tissue
- 1 Pre-wash tissue fragments
- 2 EDTA chelation buffer treatment
- 3 Isolate crypts by vigorous resuspension
- 4 Pellet and separate crypts from single cells
- 5 Optional: Mild enzymatic digestion for mouse colon crypts
- 1 Extended EDTA treatment for adenoma-containing tissue
- 2 Wash adenoma fragments
- 3 Collagenase/dispase digestion for adenoma and cancer tissue
- 4 Collect and pellet dissociated adenoma/cancer cells
- 1 Count crypts/cells and prepare Matrigel embedding
- 2 Seed organoids in 48-well plates
- 3 Polymerize Matrigel
- 4 Overlay basal culture medium with growth factors
- 1 Monitor organoid morphology and growth
- 2 Change culture medium
- 3 Passage organoids (1:5 split) for long-term culture
- 4 Monitor for senescence
- 1 Induce differentiation by withdrawing Wnt
- 2 Promote goblet and enteroendocrine differentiation
- 3 Notch pathway inhibition for alternative differentiation
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Sato et al., 2011. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol